MoneyWorks4Me

Glenmark Pharmaceuticals informs about media release

27 May 2020 Evaluate

Glenmark Pharmaceuticals has informed that it has enclosed a media release on 27th May 2020 titled ‘Glenmark Pharmaceuticals receives ANDA approval for Chlorzoxazone Tablets USP, 375 mg and 750 mg; Glenmark’s first ANDA approval out of their new US facility’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1757.85
Dr. Reddys Labs. 1169.45
Cipla 1298.75
Lupin 1966.60
Zydus Lifesciences 1112.00
View more..